Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …

Health Technology Assessment Volume, 2017 - discovery.ucl.ac.uk
BACKGROUND: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …

JAC Sterne, PN Bodalia, PA Bryden… - Health Technology …, 2017 - cir.nii.ac.jp
抄録< jats: sec id=" abs1-1">< jats: title> Background</jats: title>< jats: p> Warfarin is
effective for stroke prevention in atrial fibrillation (AF), but anticoagulation is underused in …

[HTML][HTML] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …

JA Sterne, PN Bodalia… - Health …, 2017 - research-information.bris.ac.uk
BACKGROUND: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …

JA Sterne, PN Bodalia, PA Bryden… - Health technology …, 2017 - eprints.whiterose.ac.uk
BACKGROUND: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …

JA Sterne, PN Bodalia, PA Bryden… - Health technology …, 2017 - pure.york.ac.uk
BACKGROUND: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

[HTML][HTML] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …

JA Sterne, PN Bodalia, PA Bryden… - Health Technology …, 2017 - europepmc.org
Background Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

[PDF][PDF] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …

JAC Sterne, PN Bodalia, PA Bryden, PA Davies… - researchgate.net
Jonathan AC Sterne, 1* Pritesh N Bodalia, 2, 3 Peter A Bryden, 1 Philippa A Davies, 1 Jose
A López-López, 1 George N Okoli, 1 Howard HZ Thom, 1 Deborah M Caldwell, 1 Sofia Dias …

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …

JA Sterne, PN Bodalia, PA Bryden… - Health technology …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …

JAC Sterne, PN Bodalia, PA Bryden… - Health Technology …, 2017 - journalslibrary.nihr.ac.uk
Background Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

[PDF][PDF] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …

JAC Sterne, PN Bodalia, PA Bryden, PA Davies… - Assessment - core.ac.uk
Sterne, JA, Bodalia, PN, Bryden, PA, Davies, PA, López-López, JA, Okoli, GN, ... Hingorani, AD
(2017). Or Page 1 Sterne, JA, Bodalia, PN, Bryden, PA, Davies, PA, López-López, J. A., Okoli, GN …